Home

Moderna, Inc. - Common Stock (MRNA)

27.60
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 2nd, 4:35 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Yearsbenzinga.com
Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.
Via Benzinga · October 1, 2025
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · October 1, 2025
Moderna Stock Is Rallying Wednesday: What's Driving The Action?benzinga.com
Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.
Via Benzinga · October 1, 2025
Which S&P500 stocks are moving on Wednesday?chartmill.com
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · October 1, 2025
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Studystocktwits.com
Via Stocktwits · September 23, 2025
Is Moderna Gaining or Losing Market Support?benzinga.com
Via Benzinga · September 22, 2025
2 Beaten-Down Stocks to Buy and Hold for a Decadefool.com
These biotechs should benefit from their innovative ways.
Via The Motley Fool · September 30, 2025
Global Markets Brace for Impact as US Government Shutdown Looms
Washington D.C. – Global financial markets are once again gripped by uncertainty as a potential United States government shutdown looms, threatening to disrupt critical economic data releases and send ripples through currency markets. As of late September 2025, the prospect of an impasse in Washington over funding bills has heightened
Via MarketMinute · September 29, 2025
Stay informed with the top movers within the S&P500 index on Friday.chartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · September 26, 2025
Pharma Tariffs Back In Spotlight On New Trump Threatinvestors.com
President Donald Trump threatened 100% tariffs on some drug imports.
Via Investor's Business Daily · September 26, 2025
These S&P500 stocks are moving in today's sessionchartmill.com
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · September 26, 2025
Gapping S&P500 stocks in Friday's sessionchartmill.com
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.
Via Chartmill · September 26, 2025
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'benzinga.com
Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.
Via Benzinga · September 26, 2025
Stay informed with the top movers within the S&P500 index on Thursday.chartmill.com
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · September 25, 2025
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centrebenzinga.com
Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."
Via Benzinga · September 25, 2025
Flagship Pioneering, Creator Of Moderna, Launches Extuitive With $20M To Reinvent Consumer Products Using AI Shoppersbenzinga.com
Via Benzinga · September 23, 2025
Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Showsbenzinga.com
Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the LP.8.1-targeting formula.
Via Benzinga · September 23, 2025
Stocks making big moves yesterday: Plug Power, Moderna, Magnite, Compass, and RE/MAX
Check out the companies making headlines yesterday:
Via StockStory · September 23, 2025
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'benzinga.com
President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current medical recommendations.
Via Benzinga · September 22, 2025
Why Moderna (MRNA) Stock Is Trading Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.1% in the afternoon session after the company announced it delivered the first mRNA vaccines fully manufactured in Canada to the nation's provinces and territories. 
Via StockStory · September 22, 2025
Which S&P500 stocks are moving on Monday?chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · September 22, 2025
Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday?benzinga.com
Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts.
Via Benzinga · September 22, 2025
Top S&P500 movers in Monday's sessionchartmill.com
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · September 22, 2025
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · September 22, 2025
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skidsinvestors.com
Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.
Via Investor's Business Daily · September 19, 2025